Astrazeneca Lp Drug Patent Portfolio

Astrazeneca Lp's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Astrazeneca Lp News

The Future of Ozempic and Other GLP-1 Medications: What to Expect by 2026

05 Jan, 2026

AZN and Daiichi's Enhertu Receives Breakthrough Designation for Broader Cancer Application - TradingView

22 Dec, 2025

AZN and Daiichi's Enhertu Approved by FDA for Initial Treatment of Breast Cancer - Finviz

16 Dec, 2025

AstraZeneca vs. Merck: Which Cancer Treatment Leader Holds the Advantage? - Yahoo Finance

27 Nov, 2025

See More